Cargando…
LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
BACKGROUND: Glioma is characterized by high morbidity, high mortality, and poor prognosis. Despite tremendous advances in the treatment of glioma, the prognosis of patients with glioma is still unsatisfactory. There is an urgent need to discover novel molecular markers that effectively predict progn...
Autores principales: | Zhu, Xuqiang, Chen, Di, Sun, Yiyu, Yang, Shuo, Wang, Weiguang, Liu, Bing, Gao, Peng, Li, Xueyuan, Wu, Lixin, Ma, Siqi, Lin, Wenyang, Ma, Jiwei, Yan, Dongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901081/ https://www.ncbi.nlm.nih.gov/pubmed/36747161 http://dx.doi.org/10.1186/s12885-023-10594-y |
Ejemplares similares
-
Neuroendoscopic treatment of multiple intracranial arachnoid cysts: a case report
por: Chen, Di, et al.
Publicado: (2018) -
LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in Glioma
por: Shi, Fei, et al.
Publicado: (2023) -
Retracted Article: LncRNA SNHG5 regulates the cell viability and apoptosis of glioma cells by the miR-1297/KPNA2 axis
por: Li, Xueyuan, et al.
Publicado: (2020) -
Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression
por: Wu, Lixin, et al.
Publicado: (2019) -
The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2
por: Li, Boyan, et al.
Publicado: (2022)